Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 2, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 2, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site itching; Generalised itchi... | Ongoing |
| May 2, 2017 | Human | Unknown | Florfenicol Inj Sol 30% W Pg | Injection site irritation | Outcome Unknown |
| May 1, 2017 | Human | Unknown | Tilmicosin | Chest discomfort NOS; Dizziness | Outcome Unknown |
| May 1, 2017 | Human | Unknown | Spinosad | Rash; Itching; Local swelling (not application site); Hives (see also 'Skin')... | Ongoing |
| May 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Respiratory distress; Throat irritation | Ongoing |
| May 1, 2017 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site lesion; Injection site bleeding | Outcome Unknown |
| May 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site reaction NOS; Dispenser, Abnormal; Lot # and/or Expiration d... | Recovered/Normal |
| May 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC) | Ongoing |
| May 1, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Apr 30, 2017 | Human | Unknown | Oxytetracycline Dihydrate | Injection site bleeding; Injection site reddening; Accidental exposure | Recovered/Normal |
| Apr 30, 2017 | Human | Unknown | Enrofloxacin | Injection site bleeding; Injection site stiffness; Injection site pain | Recovered/Normal |
| Apr 29, 2017 | Human | Unknown | Enrofloxacin | Injection site skin discolouration; Injection site reaction NOS | Outcome Unknown |
| Apr 28, 2017 | Human | Unknown | Melarsomine Dihydrochloride Injection | Injection site swelling; Injection site paraesthesia | Recovered/Normal |
| Apr 28, 2017 | Human | Unknown | Gonadotropin Releasing Factor (Gnrf) ... | Injection site lesion; Injection site irritation | Outcome Unknown |
| Apr 27, 2017 | Human | Unknown | Prednisolone; Miconazole; Polymyxin B | Burning sensation of eye | Ongoing |
| Apr 27, 2017 | Human | Unknown | Tildipirosin Injectable | Injection site bruising; Injection site lump | Recovered/Normal |
| Apr 26, 2017 | Human | Unknown | Moxidectin | Pigmentation disorder | Outcome Unknown |
| Apr 25, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Deafness; Tinnitus; Appetite loss; Lethargy (see also Central nervous system ... | Outcome Unknown |
| Apr 24, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Dermatitis; Itchy skin; Rash | Recovered/Normal |
| Apr 24, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Stomach upset; Accidental exposure | Outcome Unknown |
| Apr 24, 2017 | Human | Unknown | Maropitant Citrate | Eye irritation; Eye redness; Accidental exposure | Outcome Unknown |
| Apr 24, 2017 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site pain; Injection site swelling; Injection site reaction NOS | Outcome Unknown |
| Apr 24, 2017 | Human | Unknown | Phytosphingosine Salicyloyl; Chlorhex... | Hives (see also 'Skin') | Recovered/Normal |
| Apr 23, 2017 | Human | Unknown | Moxidectin | Eye irritation; Accidental exposure | Outcome Unknown |
| Apr 23, 2017 | Human | Unknown | Eprinomectin 5% Injection | Skin disorders NOS | Outcome Unknown |
| Apr 22, 2017 | Human | Unknown | Doramectin; Phenol | Musculoskeletal disorder NOS; Systemic disorder NOS; Diarrhoea; Lethargy (see... | Outcome Unknown |
| Apr 20, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Apr 20, 2017 | Human | Unknown | Milbemycin Oxime; Praziquantel | Tingling sensation | Recovered/Normal |
| Apr 20, 2017 | Human | Unknown | Milbemycin Oxime; Praziquantel | Tingling sensation | Recovered/Normal |
| Apr 19, 2017 | Human | Unknown | Dexmedetomidine Hydrochloride | Injection site pain; Injection site reaction NOS; Slow reflexes; Drowsiness -... | Ongoing |
| Apr 19, 2017 | Human | Unknown | Tilmicosin | Injection site swelling; Accidental exposure | Outcome Unknown |
| Apr 18, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC) | Recovered/Normal |
| Apr 16, 2017 | Human | Unknown | Desoxycortone | Burning sensation (skin) | Outcome Unknown |
| Apr 15, 2017 | Human | Unknown | Moxidectin | Bad taste; Throat irritation; Earache; Cough; Shivering; General pain (see ot... | Outcome Unknown |
| Apr 14, 2017 | Human | Unknown | Doramectin; Phenol | Oedema NOS (see other SOCs for specific oedemas); Reddening of the skin; Brui... | Outcome Unknown |
| Apr 14, 2017 | Human | Unknown | Tulathromycin | Light headedness; Tongue disorder NOS | Outcome Unknown |
| Apr 14, 2017 | Human | Unknown | Florfenicol | Injection site itching | Recovered/Normal |
| Apr 14, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Apr 13, 2017 | Human | Unknown | Ivermectin 0.5% Pour-On Topical Solution | Nausea; Dizziness; Light headedness | Outcome Unknown |
| Apr 13, 2017 | Human | Unknown | Olive Oil; Sodium Hydroxide; Phenoxye... | Dizziness; Breathing difficulty; Panic attack | Outcome Unknown |
| Apr 13, 2017 | Human | Unknown | Fluralaner Chew Tablets | Generalised rash | Ongoing |
| Apr 12, 2017 | Human | Unknown | Tresaderm Dermatological Solution | Eyelid oedema; Accidental exposure | Recovered/Normal |
| Apr 11, 2017 | Human | Unknown | Moxidectin | Oral cavity disorder NOS; Throat irritation; Generalised itching; Bad taste | Ongoing |
| Apr 10, 2017 | Human | Unknown | Sometribove | Injection site pain; Injection site oedema | Outcome Unknown |
| Apr 7, 2017 | Human | Unknown | Carprofen | Cough | Recovered/Normal |
| Apr 6, 2017 | Human | Unknown | Fluralaner Chew Tablets | Urticarial erythema; Skin inflammation NOS | Ongoing |
| Apr 6, 2017 | Human | Unknown | Trilostane | Rash | Outcome Unknown |
| Apr 5, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Outcome Unknown |
| Apr 4, 2017 | Human | Unknown | Dinoprost Tromethamine | Miscarriage | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.